These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27910741)

  • 21. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior.
    Li Y; Liu R; Yang J; Shi Y; Ma G; Zhang Z; Zhang X
    Biomaterials; 2015 Feb; 41():1-14. PubMed ID: 25522960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic acid-grafted polyamidoamine dendrimers enable long circulation and active tumor targeting simultaneously.
    Qi X; Fan Y; He H; Wu Z
    Carbohydr Polym; 2015 Aug; 126():231-9. PubMed ID: 25933544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids.
    Jyoti A; Fugit KD; Sethi P; McGarry RC; Anderson BD; Upreti M
    Sci Rep; 2015 Oct; 5():15236. PubMed ID: 26468877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper-topotecan complexation mediates drug accumulation into liposomes.
    Taggar AS; Alnajim J; Anantha M; Thomas A; Webb M; Ramsay E; Bally MB
    J Control Release; 2006 Aug; 114(1):78-88. PubMed ID: 16842880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in development of targeted liposomal therapeutics.
    Sawant RR; Torchilin VP
    AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel core-shell lipid nanoparticle for improving oral administration of water soluble chemotherapeutic agents: inhibited intestinal hydrolysis and enhanced lymphatic absorption.
    Wang T; Shen L; Zhang Z; Li H; Huang R; Zhang Y; Quan D
    Drug Deliv; 2017 Nov; 24(1):1565-1573. PubMed ID: 29029577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.
    Zucker D; Barenholz Y
    J Control Release; 2010 Sep; 146(3):326-33. PubMed ID: 20685223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats.
    Ma Y; Yang Q; Wang L; Zhou X; Zhao Y; Deng Y
    Eur J Pharm Sci; 2012 Apr; 45(5):539-45. PubMed ID: 22155543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-sensitive liposomes bearing a chemotherapeutic agent and a natural apoptosis modulator for effective intracellular delivery to the solid tumor.
    Saraf S; Jain SK
    Drug Deliv Transl Res; 2023 Dec; 13(12):2961-2981. PubMed ID: 37306925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
    Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB
    J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.
    Fugit KD; Jyoti A; Upreti M; Anderson BD
    J Control Release; 2015 Jan; 197():10-9. PubMed ID: 25456833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel.
    Chang G; Ci T; Yu L; Ding J
    J Control Release; 2011 Nov; 156(1):21-7. PubMed ID: 21777632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nigericin-mediated liposome loading of topotecan: is nigericin a potential drug release regulator?
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
    Int J Pharm; 2010 Oct; 399(1-2):31-6. PubMed ID: 20678563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
    Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
    Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered liposomes bearing camptothecin analogue for tumour targeting:
    Saraf S; Jain A; Tiwari A; Verma A; Jain SK
    J Liposome Res; 2021 Dec; 31(4):326-341. PubMed ID: 32718195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan.
    Subramanian D; Muller MT
    Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan.
    Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y
    J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.